DOP2002000415A - HIV PROTEASE INHIBITORS, COMPOSOTIONS CONTAINING THE SAME, ITS PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS. - Google Patents

HIV PROTEASE INHIBITORS, COMPOSOTIONS CONTAINING THE SAME, ITS PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS.

Info

Publication number
DOP2002000415A
DOP2002000415A DO2002000415A DO2002000415A DOP2002000415A DO P2002000415 A DOP2002000415 A DO P2002000415A DO 2002000415 A DO2002000415 A DO 2002000415A DO 2002000415 A DO2002000415 A DO 2002000415A DO P2002000415 A DOP2002000415 A DO P2002000415A
Authority
DO
Dominican Republic
Prior art keywords
compounds
hiv protease
synthesis
pharmaceutical
composotions
Prior art date
Application number
DO2002000415A
Other languages
Spanish (es)
Inventor
Gary Louis Bolton
Stephen E Webber
Stacie S Canon-Koch
Therese N Alexander
Barvian Mark
Fredrick E Boyer
Bejamin J Burke
Tod Holler
Tanya M Jewell
Josyula Vara Prasad
David J Kucera
Maria A Linton
Jeff Machak
Lennert J Mitchell
Sean T Murphy
Siegfried H Reich
Donald J Skalitzky
John H Tatlock
Michael D Varney
Scott C Virgil
Stephen T Worland
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Priority to DO2002000415A priority Critical patent/DOP2002000415A/en
Publication of DOP2002000415A publication Critical patent/DOP2002000415A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se revelan compuestos de la fórmula: donde las variables de fórmula son tales como las antes definidas aquí, que inhiben o bloquean ventajosamente la actividad biológica de la proteasa del VIH. Estos compuestos, asf como las composiciones farmacéuticas que contienen estos compuestos, son útiles para el tratamiento de pacientes o huéspedes infectados con el virus VIH. También se describen productos intermedios y métodos de síntesis para la preparación de tales compuestos.Compounds of the formula are revealed: where the formula variables are such as those defined hereinbefore, which advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as the pharmaceutical compositions containing these compounds, are useful for the treatment of patients or guests infected with the HIV virus. Intermediates and synthesis methods for the preparation of such compounds are also described.

DO2002000415A 2002-06-11 2002-06-11 HIV PROTEASE INHIBITORS, COMPOSOTIONS CONTAINING THE SAME, ITS PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS. DOP2002000415A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2002000415A DOP2002000415A (en) 2002-06-11 2002-06-11 HIV PROTEASE INHIBITORS, COMPOSOTIONS CONTAINING THE SAME, ITS PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2002000415A DOP2002000415A (en) 2002-06-11 2002-06-11 HIV PROTEASE INHIBITORS, COMPOSOTIONS CONTAINING THE SAME, ITS PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS.

Publications (1)

Publication Number Publication Date
DOP2002000415A true DOP2002000415A (en) 2003-01-15

Family

ID=44261083

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2002000415A DOP2002000415A (en) 2002-06-11 2002-06-11 HIV PROTEASE INHIBITORS, COMPOSOTIONS CONTAINING THE SAME, ITS PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS.

Country Status (1)

Country Link
DO (1) DOP2002000415A (en)

Similar Documents

Publication Publication Date Title
PA8547501A1 (en) HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS
CO2022018811A2 (en) Kras g12c protein inhibitors and their uses
PE20181045A1 (en) USEFUL COMPOUNDS AS IMMUNOMODULATORS
UY29458A1 (en) REPLACED HETEROCICLES AND USES OF THE SAME
CR7716A (en) USE OF IKB-KINASE INHIBITORS FOR PAIN TREATMENT
PA8583401A1 (en) NEW TRIAZOL COMPOUNDS AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF)
ECSP088099A (en) NEW DERIVATIVES OF 2-AZETIDINONE FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES
ECSP078052A (en) NEW DERIVATIVES OF 2-AZETIDINONE AS INHIBITORS OF CHOLESTEROL ABSORPTION FOR THE TREATMENT OF HYPERLIPIDEMIC CONDITIONS
PA8582701A1 (en) NEW OXAZOL AND TIAZOL COMPOUNDS AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF)
UY27882A1 (en) CHEMICAL COMPOUNDS
ECSP078051A (en) NEW DERIVATIVES OF 2-AZETIDINONE AS INHIBITORS OF CHOLESTEROL ABSORPTION FOR THE TREATMENT OF HYPERLIPIDEMIC CONDITIONS
SV2004001690A (en) NEW DERIVATIVES OF HETEROCICLIC FLUOROGLYCOSIDS, MEDICINES CONTAINING THESE COMPOUNDS, AND THE USE OF THE SAME
UY28691A1 (en) DERIVATIVES OF DIFENILAZETIDONA
DOP2000000108A (en) ANTI-CORPOVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES, AND MATERIALS FOR SYNTHESIS
UY29087A1 (en) ADAMANTILE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USE
PA8583101A1 (en) NEW COMPOUNDS OF ISOTIAZOL AND ISOXAZOL AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF)
CL2004000848A1 (en) COMPOUNDS DERIVED FROM FENACIL-2-HIDROXI-3-DIAMINOALCANS, INHIBITORS OF THE ENZYME BETASECRETASA, USEFUL TO PREPARE A MEDICINAL PRODUCT TO TREAT ALZHEIMER, DOWN SYNDROME, HEREDITAR CEREBRAL HERIDAL AND OEREDOS
SV2004001548A (en) DIFENILAZETIDINONAS REPLACED IN ACID GROUP, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THESE COMPOUNDS AND THEIR USE
AR123685A1 (en) MRGX2 ANTAGONISTS
SV2004001555A (en) DIFENILAZETIDINONES CATIONICAMENTE REPLACED, PROCESSES FOR THEIR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS AND THEIR USES
PY2039849A (en) 3,6-DIAMINO-PYRIDAZINE-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS
MX2022002437A (en) METHODS FOR THE PRODUCTION OF RECOMBINANT HUMAN ARGINASE 1 AND ITS USES.
HN2003000162A (en) DERIVATIVES OF ISOINDOLONE, PREPARATION PROCESS AND INTERMEDIATE COMPOUNDS OF THIS PROCESS, ITS USE AS MEDICATIONS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
UY26666A1 (en) ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES AND THE MATERIALS FOR THEIR SYNTHESIS
MX2024008372A (en) Deuterated organic compounds and their uses